Glossary
Grant L Davis
FDA Investigator Details
Grant L Davis
Visit Investigator ProfileInvestigation Details
Last Issued Date
March 11, 2011
Conversion Rate
0
% Conversion
No. of 483’s Issued
2
Warning Letters Issued
0
Countries Inspected
USA
FDA Investigators having one site common
Detailed Analysis
Approach:
Investigator Davis's approach leans heavily on ensuring the SOPs are clearly defined and adhered to, and that cleanliness is maintained at all stages of the process. He places great emphasis on the correct handling of infectious materials to prevent cross-contamination.
Profile:
Grant L Davis is an FDA investigator with a high focus on cleanliness and proper operating procedures to prevent cross contamination. His primary interest is rooted in the understanding and handling of infectious agents, in this case, Salmonella enteritidis (SE). His inspections often emphasize proper handling and disposal of critical materials.
Top Process Types:
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now
